As of March 2026 BioSpecifics Technologies has a market cap of A$0.92 Billion. This makes BioSpecifics Technologies the world's 6666th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.